Followers | 1324 |
Posts | 128332 |
Boards Moderated | 1 |
Alias Born | 08/28/2009 |
Tuesday, July 14, 2020 11:05:43 AM
My opinions and comments are exactly that. They are not a recommendation to either buy or sell any security.
Recent INMB News
- INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update • GlobeNewswire Inc. • 03/28/2024 08:01:53 PM
- INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™ • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
- INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024 • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:02:36 PM
- INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:00:28 PM
- INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 01/02/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:15:31 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 12/18/2023 09:05:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:01:18 PM
- INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA • GlobeNewswire Inc. • 12/18/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:00:09 PM
- INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 11/29/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:00:36 PM
- INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease • GlobeNewswire Inc. • 11/27/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:13:29 PM
- INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe • GlobeNewswire Inc. • 11/15/2023 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 04:31:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:13:09 PM
- INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update • GlobeNewswire Inc. • 11/01/2023 08:10:41 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM